Frequency Therapeutics Stock Analysis

Frequency Stock Analysis Notes

About 93.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.2. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Frequency Therapeutics recorded a loss per share of 9.42. The entity had not issued any dividends in recent years. The firm had 1:50 split on the 6th of November 2023. To find out more about Frequency Therapeutics contact Ram MBA at 617 468 1999 or learn more at https://www.korrobio.com.

Frequency Therapeutics Investment Alerts

Frequency Largest EPS Surprises

View All Earnings Estimates

Frequency Therapeutics Environmental, Social, and Governance (ESG) Scores

Frequency Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 118.38 M.

Frequency Profitablity

Management Efficiency

Frequency Therapeutics has return on total asset (ROA) of (0.2916) % which means that it has lost $0.2916 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6346) %, meaning that it created substantial loss on money invested by shareholders. Frequency Therapeutics' management efficiency ratios could be used to measure how well Frequency Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 10th of February 2026, Return On Tangible Assets is likely to drop to -0.35. In addition to that, Return On Capital Employed is likely to drop to -0.41. At this time, Frequency Therapeutics' Non Current Assets Total are very stable compared to the past year. As of the 10th of February 2026, Non Currrent Assets Other is likely to grow to about 7.5 M, while Total Assets are likely to drop about 173.2 M.

Technical Drivers

As of the 10th of February, Frequency Therapeutics shows the Standard Deviation of 11.07, mean deviation of 4.96, and Variance of 122.64. Frequency Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Frequency Therapeutics Price Movement Analysis

Frequency Therapeutics Insider Trading Activities

Frequency Therapeutics Outstanding Bonds

Frequency Therapeutics Predictive Daily Indicators

Frequency Therapeutics Corporate Filings

Frequency Therapeutics Forecast Models

Frequency Therapeutics' time-series forecasting models are one of many Frequency Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Frequency Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Frequency Therapeutics Bond Ratings

Frequency Therapeutics financial ratings play a critical role in determining how much Frequency Therapeutics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Frequency Therapeutics' borrowing costs.

Frequency Therapeutics Total Assets Over Time

Frequency Therapeutics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Frequency Therapeutics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Frequency Therapeutics Debt Ratio

22.0

It appears that most of the Frequency Therapeutics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Frequency Therapeutics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Frequency Therapeutics, which in turn will lower the firm's financial flexibility.

Frequency Therapeutics Corporate Bonds Issued

Frequency Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Frequency Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Frequency shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Frequency Therapeutics. By using and applying Frequency Stock analysis, traders can create a robust methodology for identifying Frequency entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Frequency analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Frequency analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Frequency Therapeutics stock analysis indicators help investors evaluate how Frequency Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Frequency Therapeutics shares will generate the highest return on investment. By understating and applying Frequency Therapeutics stock analysis, traders can identify Frequency Therapeutics position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Frequency Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Frequency Stock, please use our How to Invest in Frequency Therapeutics guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Understanding Frequency Therapeutics requires distinguishing between market price and book value, where the latter reflects Frequency's accounting equity. The concept of intrinsic value - what Frequency Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Frequency Therapeutics' price substantially above or below its fundamental value.

Understanding that Frequency Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Frequency Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Frequency Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.